Back to Search Start Over

KRAS AND BRAF MUTATIONAL ANALYSES IN A PHASE II TRIAL OF FIRST-LINE FOLFOXIRI PLUS BEVACIZUMAB (BV) IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS)

Details

Database :
OpenAIRE
Journal :
Università di Pisa-IRIS
Accession number :
edsair.dedup.wf.001..792025bf7a2e0b71041741ca55b753ad